Review

December 28, 2022


Non-alcoholic fatty liver disease: Definition and subtypes
Seul Ki Han, Soon Koo Baik, Moon Young Kim
Clin Mol Hepatol. 2023;29(suppl):S5-S16.

Review

November 29, 2022


MAFLD: How is it different from NAFLD?
Cameron Gofton, Yadhavan Upendran, Ming-Hua Zheng, et al.
Clin Mol Hepatol. 2023;29(Suppl):S17-S31.

Review

December 14, 2022


Global incidence and prevalence of nonalcoholic fatty liver disease
Margaret LP Teng, Cheng Han Ng, Daniel Q. Huang, et al.
Clin Mol Hepatol. 2023;29(Suppl):S32-S42.

Review

November 22, 2022


Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease
Peter Konyn, Aijaz Ahmed, Donghee Kim
Clin Mol Hepatol. 2023;29(Suppl):S43-S57.

Review

December 5, 2022


Comparison between obese and non-obese nonalcoholic fatty liver disease
Wah-Kheong Chan
Clin Mol Hepatol. 2023;29(Suppl):S58-S67.

Review

December 5, 2022


Interaction between sarcopenia and nonalcoholic fatty liver disease
Sae Kyung Joo, Won Kim
Clin Mol Hepatol. 2023;29(Suppl):S68-S78.

Review

December 14, 2022


Risk factors in nonalcoholic fatty liver disease
Eunji Ko, Eileen L. Yoon, Dae Won Jun
Clin Mol Hepatol. 2023;29(Suppl):S79-S85.

Review

January 5, 2023


Nonalcoholic fatty liver disease and non-liver comorbidities
Richie Manikat, Mindie H. Nguyen
Clin Mol Hepatol. 2023;29(Suppl):s86-s102.

Review

November 30, 2022


Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, et al.
Clin Mol Hepatol. 2023;29(Suppl):S103-S122.

Review

December 12, 2022


Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
Asako Nogami, Masato Yoneda, Michihiro Iwaki, et al.
Clin Mol Hepatol. 2023;29(Suppl):S123-S135.

Review

December 12, 2022


Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
Jung Hwan Yu, Han Ah Lee, Seung Up Kim
Clin Mol Hepatol. 2023;29(Suppl):S136-S149.

Review

January 25, 2023


Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Sang Bong Ahn
Clin Mol Hepatol. 2023;29(Suppl):S150-S156.

Review

November 22, 2022


Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
Tina Reinson, Ryan M. Buchanan, Christopher D. Byrne
Clin Mol Hepatol. 2023;29(Suppl):S157-S170.

Review

December 12, 2022


Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
Terry Cheuk-Fung Yip, Fei Lyu, Huapeng Lin, et al.
Clin Mol Hepatol. 2023;29(Suppl):S171-S183.

Review

December 5, 2022


Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clin Mol Hepatol. 2023;29(Suppl):S184-S195.

Review

December 5, 2022


Identification of high-risk subjects in nonalcoholic fatty liver disease
Christiane Stern, Laurent Castera
Clin Mol Hepatol. 2023;29(Suppl):S196-S206.

Review

September 14, 2022


Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Karim Seif El Dahan, Darine Daher, Amit G. Singal
Clin Mol Hepatol. 2023;29(Suppl):S207-S219.

Review

November 10, 2022


Preventive strategy for nonalcoholic fatty liver disease-related hepatocellular carcinoma
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Clin Mol Hepatol. 2023;29(Suppl):S220-S227.

Review

December 14, 2022


Surveillance of the progression and assessment of treatment endpoints for nonalcoholic steatohepatitis
Yi-wen Shi, Jian-Gao Fan
Clin Mol Hepatol. 2023;29(Suppl):S228-S243.

Review

December 14, 2022


Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver disease
Georg Semmler, Christian Datz, Michael Trauner
Clin Mol Hepatol. 2023;29(Suppl):S244-S260.

Review

December 22, 2022


The effects of moderate alcohol consumption on non-alcoholic fatty liver disease
Hyunwoo Oh, Won Sohn, Yong Kyun Cho
Clin Mol Hepatol. 2023;29(Suppl):S261-S267.

Review

December 20, 2022


Pharmacological advances in the treatment of nonalcoholic fatty liver diseases : focused on global results of randomized controlled trials
Jihyun An, Joo Hyun Sohn
Clin Mol Hepatol. 2023;29(Suppl):S268-S275.

Review

December 22, 2022


Bariatric surgery for non-alcoholic fatty liver disease: Indications and post-operative management
Anja Geerts, Sander Lefere
Clin Mol Hepatol. 2023;29(Suppl):S276-S285.

Review

December 28, 2022


Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management
Sara Battistella, Francesca D’Arcangelo, Marco Grasso, et al.
Clin Mol Hepatol. 2023;29(Suppl):S286-S301.

Review

November 15, 2022


Non-alcoholic fatty liver disease: the pathologist’s perspective
Wei-Qiang Leow, Anthony Wing-Hung Chan, Paulo Giovanni L. Mendoza, et al.
Clin Mol Hepatol. 2023;29(Suppl):S302-S318.

Original Article

December 14, 2022


The independent effect of exercise on biopsy-proven non-alcoholic fatty liver disease: A systematic review
George Chen, Bubu Banini, Albert Do, et al.
Clin Mol Hepatol. 2023;29(Suppl):S319-S332.


Articles in E-pub version are posted online ahead of regular printed publication.

Original Article
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
Received March 3, 2023  Accepted March 21, 2023  
View: 235   Download: 25
Editorial
Toward user-friendly and evidence-based practice guidelines for hepatocellular carcinoma
Do Young Kim
Received March 15, 2023  Accepted March 15, 2023  
View: 73   Download: 3
Review
Clinical practice guidelines and real-life practice in hepatocellular carcinoma: a Japanese perspective
Hironori Koga, Hideki Iwamoto, Hiroyuki Suzuki, Shigeo Shimose, Masahito Nakano, Takumi Kawaguchi
Received March 12, 2023  Accepted March 20, 2023  
View: 128   Download: 19
Editorial
Challenges in Translating Clinical Practice Guidelines into Real-Life Practice for the management of hepatocellular carcinoma in Taiwan
San-Chi Chen
Received March 11, 2023  Accepted March 17, 2023  
View: 83   Download: 4
Clinical practice guidelines and real-world practice for hepatocellular carcinoma in Taiwan: Bridging the gap
Shen-Yung Wang
Received February 28, 2023  Accepted March 16, 2023  
View: 64   Download: 4
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
Philipp Kasper, Münevver Demir, Hans-Michael Steffen
Received February 15, 2023  Accepted March 16, 2023  
View: 62   Download: 4
Is liver biopsy mandatory to identify immune-tolerant phase of chronic hepatitis B?
Joo Hyun Oh, Dong Hyun Sinn
Received February 10, 2023  Accepted March 15, 2023  
View: 49   Download: 1
Review
Acute -on- Chronic liver failure – Terminology, Mechanisms and Management
Vinay Kumar BR, Shiv Kumar Sarin
Received April 16, 2022  Accepted February 25, 2023  
View: 139   Download: 25
Editorial
Management of Hepatocellular Carcinoma in China: Seeking Common Grounds While Reserving Differences
Tian Yang, Ming-Da Wang, Xin-Fei Xu, Chao Li, Han Wu, Feng Shen
Received March 14, 2023  Accepted March 15, 2023  
View: 106   Download: 11
The effect of moderate alcohol consumption on nonalcoholic fatty liver disease
Ji-Won Park, Ki Tae Suk
Received March 1, 2023  Accepted March 15, 2023  
View: 82   Download: 12
What should be done to reduce the discrepancy between guidelines and real-life practice for HCC in Korea?
Min Kyung Park, Yoon Jun Kim
Received February 28, 2023  Accepted March 14, 2023  
View: 61   Download: 0
The clinical management of HCC in China: progresses and challenges
Shan Shan, Jidong Jia
Received February 28, 2023  Accepted March 13, 2023  
View: 87   Download: 10
The current trends in the health burden of primary liver cancer across the globe
Peter Konyn, Aijaz Ahmed, Donghee Kim
Received March 4, 2023  Accepted March 11, 2023  
View: 110   Download: 6
Changing the nomenclature from NAFLD to MAFLD is more than a change in terminology
Eileen Laurel Yoon, Dae Won Jun
Received March 1, 2023  Accepted March 13, 2023  
View: 100   Download: 11
Editorial: HCC surveillance in non-alcoholic fatty liver disease – who and how?
Margaret LP Teng, Darren Jun Hao Tan, Cheng Han Ng, Daniel Q. Huang
Received February 23, 2023  Accepted March 13, 2023  
View: 97   Download: 4
Implications of comorbidities in nonalcoholic fatty liver disease
Sherlot Juan Song, Vincent Wai-Sun Wong
Received February 16, 2023  Accepted March 11, 2023  
View: 111   Download: 11
Review
Safety Considerations for Withdrawal of Nucleos(t)ide Analogues in Patients with Chronic Hepatitis B: First, Do No Harm
Yao-Chun Hsu, Cheng-Hao Tseng, Jia-Horng Kao
Received November 26, 2022  Accepted March 13, 2023  
View: 125   Download: 22
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: Asian perspective comparison
Yuri Cho, Bo Hyun Kim, Joong-Won Park
Received March 9, 2023  Accepted March 9, 2023  
View: 187   Download: 29
Editorial
The prime time for management of hepatocellular carcinoma in Hong Kong
Landon L. Chan, Stephen L. Chan
Received March 7, 2023  Accepted March 8, 2023  
View: 109   Download: 5
Non-obese or lean nonalcoholic fatty liver disease matters but is it preventable or inevitable in light of its risk factors?
Heejoon Jang, Won Kim
Received March 2, 2023  Accepted March 4, 2023  
View: 140   Download: 12
The Imitator of Immune-Tolerant Phase in Chronic Hepatitis B: A Killer in Disguise
Moon Haeng Hur, Jeong-Hoon Lee
Received February 28, 2023  Accepted March 7, 2023  
View: 73   Download: 8
The latest global burden of liver cancer: A past and present threat
Joo Hyun Oh, Dae Won Jun
Received February 23, 2023  Accepted March 4, 2023  
View: 95   Download: 11
Lean vs. obese NAFLD, two phenotypes of NAFLD: look the same but different or vice versa?
Ho Soo Chun, Minjong Lee
Received February 15, 2023  Accepted March 6, 2023  
View: 85   Download: 12
Review
Hepatitis B core-related antigen: a novel and promising surrogate biomarker to guide anti-HBV therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Received December 2, 2022  Accepted March 7, 2023  
View: 222   Download: 39
Original Article
Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: A network meta-analysis
Min Jeong Park, Hayeon Kim, Myeong Gyu Kim, Kyungim Kim
Received October 22, 2022  Accepted March 6, 2023  
View: 174   Download: 18
Editorial
The growing burden of non-alcoholic fatty liver disease on mortality
Ju-Yeon Cho, Won Sohn
Received February 28, 2023  Accepted March 2, 2023  
View: 125   Download: 10
How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
Byeong Geun Song, Dong Hyun Sinn
Received January 5, 2023  Accepted February 27, 2023  
View: 130   Download: 7
Review
A decade of liver organoids: Advancements in disease modeling
Yue Liu, Jian-Ying Sheng, Junjun Ding, Yun-Shen Chan
Received November 29, 2022  Accepted February 28, 2023  
View: 245   Download: 52
Original Article
Analysis of Hepatitis C Virus Resistance-Associated Substitutions in Direct-Acting Antiviral Failure in South Korea Using Next-Generation Sequencing
Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong
Received October 28, 2022  Accepted March 1, 2023  
View: 154   Download: 26
Editorial
Editorial: Noninvasive biomarkers for liver inflammation in NAFLD: current and future
Kee-Huat Chuah, Wah-Kheong Chan
Received February 15, 2023  Accepted February 23, 2023  
View: 120   Download: 10
The Independent Effect of Exercise on Biopsy-Proven Non-Alcoholic Fatty Liver Disease: A Systematic Review
Young-Joo Jin
Received February 10, 2023  Accepted February 22, 2023  
View: 1440   Download: 33
Snapshot
Systemic therapy in advanced hepatocellular carcinoma
Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
Received February 10, 2023  Accepted February 16, 2023  
View: 191   Download: 44
Review
Acute hepatitis C virus infection: clinical update and remaining challenges
Chen-Hua Liu, Jia-Horng Kao
Received October 30, 2022  Accepted February 16, 2023  
View: 369   Download: 89
Original Article
Taurocholic Acid Promotes Hepatic Stellate Cell Activation via S1PR2/p38 MAPK/YAP Signaling under Cholestatic Conditions
Jing Yang, Xujiao Tang, Zhu Liang, Mingzhu Chen, Lixin Sun
Received October 21, 2022  Accepted February 16, 2023  
View: 360   Download: 48
Correspondance
Correspondence on Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
Jeong-Ju Yoo, Sang Gyune Kim
Received February 6, 2023  Accepted February 9, 2023  
View: 108   Download: 6
Review
Development of hepatocellular carcinoma in untreated and treated patients with chronic hepatitis B virus infection
Chih-Lin Lin, Jia-Horng Kao
Received October 31, 2022  Accepted February 12, 2023  
View: 378   Download: 73
Editorial
Non-invasive biomarkers of liver fibrosis in NAFLD
Basheer M, Naffaa ME, Assy N
Received February 6, 2023  Accepted February 8, 2023  
View: 194   Download: 39
Review
Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, Takashi Niizeki, Takumi Kawaguchi
Received November 9, 2022  Accepted February 9, 2023  
View: 341   Download: 81
Original Article
Factors Associated with Unrecognized Cirrhosis in Patients with Hepatocellular Carcinoma
Yi-Te Lee, Mohammad Karim, Hye Chung Kum, Sulki Park, Nicole E. Rich, Mazen Noureddin, Amit G. Singal, Ju Dong Yang
Received December 15, 2022  Accepted January 29, 2023  
View: 393   Download: 35
Review
Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications
Paula Fernández-Palanca, Tania Payo-Serafín, Carolina Méndez-Blanco, Beatriz San-Miguel, María J. Tuñón, Javier González-Gallego, José L. Mauriz
Received November 28, 2022  Accepted January 31, 2023  
View: 335   Download: 39
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives
Shang-Chin Huang, Chun-Jen Liu
Received November 27, 2022  Accepted January 5, 2023  
DOI: https://doi.org/10.3350/cmh.2022.0422    [Epub ahead of print]
View: 522   Download: 120
Letter to the Editor
Letter to the Editor: Letter regarding "The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase"
Chia-Ming Chu, Yun-Fan Liaw.
Received January 19, 2023  Accepted January 20, 2023  
View: 212   Download: 22
Review
Clinical practice guidelines and real-life practice for hepatocellular carcinoma in Taiwan
Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu
Received November 26, 2023  Accepted January 24, 2023  
View: 639   Download: 121
Utility of Combining PIVKA-II and AFP in the Surveillance and Monitoring of Hepatocellular Carcinoma in the Asia-Pacific Region
Do-Young KIM, Bao Nguyen TOAN, Chee-Kiat TAN, Irsan HASAN, Lyana SETIAWAN, Ming-Lung YU, Namiki IZUMI, Nguyen Nguyen HUYEN, Pierce Kah-Hoe CHOW, Rosmawati MOHAMED, Stephen Lam CHAN, Tawesak TANWANDEE, Teng-Yu LEE, Thi Thanh Nguyen HAI, Tian YANG, Woo-Chang LEE, Henry Lik Yuen CHAN
Received July 19, 2022  Accepted January 25, 2023  
View: 729   Download: 170
The role of different viral biomarkers on the management of chronic hepatitis B For special issue ‘Challenging issues in the treatment of viral hepatitis’
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
Received December 14, 2022  Accepted January 15, 2023  
View: 432   Download: 75
Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Received November 16, 2022  Accepted January 1, 2023  
DOI: https://doi.org/10.3350/cmh.2022.0404    [Epub ahead of print]
View: 467   Download: 51
Original Article
The long-term prognosis and the need for histologic assessment in chronic hepatitis B in serological immune-tolerant phase
Jeong-Ju Yoo, Soo Young Park, Ji Eun Moon, Yu Rim Lee, Han Ah Lee, Jieun Lee, Young Seok Kim, Yeon Seok Seo, Sang Gyune Kim
Received October 19, 2022  Accepted January 3, 2023  
View: 441   Download: 51
Global burden of primary liver cancer and its association with underlying aetiologies, sociodemographic status, and sex differences, 1990-2019: a DALYs-based analysis of the Global Burden of Disease 2019 study
Sungchul Choi, Beom Kyung Kim, Dong Keon Yon, Seung Won Lee, Han Gyeol Lee, Ho Hyeok Chang, Seoyeon Park, Ai Koyanagi, Louis Jacob, Elena Dragioti, Joaquim Radua, Jae Il Shin, Seung Up Kim, Lee Smith
Received October 17, 2022  Accepted December 27, 2022  
View: 721   Download: 92  Citation: 1
Review
Clinical practice guidelines and real-life practice on hepatocellular carcinoma: the Hong Kong perspective
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
Received November 14, 2022  Accepted December 23, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0399    [Epub ahead of print]
View: 664   Download: 108
Clinical practice guideline and real-life practice in hepatocellular carcinoma: Chinese perspective
Diyang Xie, Jieyi Shi, Jian Zhou, Jia Fan, Qiang Gao
Received November 15, 2022  Accepted December 20, 2022  
View: 801   Download: 174
Original Article
Single-cell phenotypes of peripheral blood immune cells in early and late stages of non-alcoholic fatty liver disease
Kathryn Jane Waller, Hajar Saihi, Wenhao Li, James Hallimond Brindley, Anja De Jong, Wing-kin Syn, Conrad Bessant, William Alazawi
Received July 14, 2022  Accepted November 16, 2022  
DOI: https://doi.org/10.3350/cmh.2022.0205    [Epub ahead of print]
View: 793   Download: 56

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 623
TOTAL : 1211788
Close layer